HomeNewsBusinessStartupCoronavirus pandemic: Indian startups pitch for complete lockdown, imposition of Section 144 across major cities

Coronavirus pandemic: Indian startups pitch for complete lockdown, imposition of Section 144 across major cities

More than 50 entrepreneurs and investors call on local administrations to take hard decisions now to protect the future.

March 17, 2020 / 17:48 IST
Story continues below Advertisement
Representative image
Representative image

The Indian startup ecosystem has come together to push for strict lockdown and imposition of Section 144 in major cities till the middle of April to avoid large scale spread of the COVID-19 pandemic which has gripped almost the entire world.

Under this section, the government can ban any form of a gathering of four or more people in an area.

Story continues below Advertisement

In a note released for public comments, more than 50 startup founders, investors and entrepreneurs have come together to prepare a strong case as to why swift action is required from local and state governments to lock down Indian cities.

India currently has more than 120 confirmed COVID-19 cases with three deaths been reported.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show